MediPoint: Vertebroplasty Devices - North America Analysis and Market Forecasts

MediPoint: Vertebroplasty Devices - North America Analysis and Market Forecasts

Summary
Vertebral compression fractures (VCFs) are often characterized by pain and deformity due to the fracture and collapse of one or more vertebral bodies in the spinal column. Primarily caused by osteoporosis and osteopenia-conditions characterized by loss of bone mass and low bone mineral density-the number of diagnosed VCF cases is increasing globally as the population ages and incidences of the aforementioned conditions grow. In general, these fractures are initially treated non-surgically with pharmacological therapies, bracing, and rest. In the event that non-surgical treatment fails to relieve pain, surgical treatment can be implemented.

North American vertebroplasty market was estimated at US$72.0M in 2016 across the three markets (Canada, Mexico, and the US) covered in this report. By the end of the forecast period in 2023, it is estimated that the market will decline to approximately US$29.4M at a negative Compound Annual Growth Rate (CAGR) of 12.0%.

Key drivers of the vertebroplasty market in the forecast period are -
- The rising prevalence of osteoporosis and osteopenia due to the increasing aging population.
- The increasing preference for minimally invasive and outpatient procedures.

The US represented the largest portion of the market in 2016, holding 77.0% of the regional revenue, while Canada is expected to hold the largest market share at the end of the forecast period. Mexico is expected to be the fastest-growing market through 2023, at a CAGR of 3.8%, while declining sales will be observed in the US at a negative CAGR of 22.8%.

The market for VCF repair products, including vertebroplasty kits, is a highly consolidated market. Together, three orthopedic conglomerates-DePuy Synthes, Medtronic, and Stryker-dominated the global market in 2016. These companies hold well-established orthopedic portfolios and enjoy wide-ranging distribution networks, which allow them to effectively cross-sell their VCF products. Several minor players also operate in regional markets, and domestic manufacturers of cheap copycat products are a threat in developing countries.

The report "MediPoint: Vertebroplasty Devices - North America Analysis and Market Forecasts" focuses on the market outlook for vertebroplasty products in North America (Canada, Mexico, and US). The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and geography.

In particular, this report provides the following -
- Overview of recent key industry events and analysis of their market impact.
- Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.
- Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.
- Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.
- Analysis of the current and future market competition in the North American vertebroplasty market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Companies mentioned in this report: DePuy Synthes, Globus Medical, Medtronic, Stryker.

Scope
- Overview of recent key industry events and analysis of their market impact.
- Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.
- Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.
- Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.
- Analysis of the current and future market competition in the North American vertebroplasty market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy
The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.
- Develop business strategies by understanding the trends shaping and driving the vertebroplasty market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the vertebroplasty market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in country-specific vertebroplasty markets from 2014-2023.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.